Sale!

(Ebook PDF) Clinical Dilemmas in Viral Liver Disease 2nd Edition by Graham Foster, Rajender Reddy

Original price was: $50.00.Current price is: $35.00.

Clinical Dilemmas in Viral Liver Disease 2nd Edition K Rajender Reddy Digital Instant Download

Author(s): K Rajender Reddy; Graham Foster
ISBN(s): 9781119533443, 1119533449
Edition: 2
File Details: PDF, 3.34 MB
Year: 2020
Language: english
SKU: EB-10841836 Category: Tags: ,

(Ebook PDF) Clinical Dilemmas in Viral Liver Disease 2nd Edition by Graham Foster, Rajender Reddy-Ebook PDF Instant Download/Delivery:9781119533443, 1119533449

Instant download Full Chapter of Clinical Dilemmas in Viral Liver Disease 2nd Edition after payment

Product details:

ISBN 10:1119533449

ISBN 13:9781119533443

Author: Graham R. Foster; K. Rajender Reddy

The only evidence-based book to approach viral liver disease by focusing exclusively on the clinical dilemmas encountered by hepatologists and their medical teams

Although viral hepatitis is a growing public health risk around the world, the World Health Organization (WHO) views the elimination of hepatitis infection over the next several as an achievable goal. Effective pharmaceutical therapies are now available, yet medical teams caring for patients with viral hepatitis are challenged when looking for answers to specific questions in the current medical literature. The second edition of Clinical Dilemmas in Viral Liver Disease provides evidence-based guidance for medical teams involved in diagnosing, treating, and managing patients with viral liver disease.

This fully updated book explores developments in new treatments and new diagnostic approaches that are contributing to WHO goals of viral elimination. Brief, easily referenced chapters examine clearly defined topics, addressing the clinical questions and difficulties encountered by medical teams in day-to-day practice. Contributions by an international team of investigators and clinicians address clinical questions and issues which are seldom found in standard textbooks and online repositories. Offering practical guidance on the specific challenges and dilemmas of treating viral liver disease, this unique volume: 

  • Provides practical, evidence-based guidance on topical and controversial issues
  • Addresses understudied questions that arise in day-to-day clinical practice
  • Discusses the challenges surrounding global elimination programs
  • Presents focused approach that is supported by current literature and expert opinion

Table of Contents:

PART I: Investigating the Liver

  1. Noninvasive markers of fibrosis: how reliable are they?

  2. Liver biopsy in chronic viral hepatitis: is there still life left in it?

  3. Screening for hepatocellular carcinoma in viral liver disease: any new biomarkers on the horizon?

  4. Realistic estimates of hepatitis C virus and hepatitis B virus disease burden

PART II: Today’s Therapies

Section 1: HCV

  1. Acute hepatitis C: treat immediately or give a chance to spontaneously clear?

  2. Is ribavirin alive or dead in the current era of HCV therapy?

  3. Hepatitis C virus genotype and viral testing, and on-treatment monitoring: necessary or overkill?

  4. Treatment of hepatitis C virus in renal disease: can we use all the drugs without additional monitoring?

  5. Does directly acting antiviral therapy improve quality of life?

  6. Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider?

  7. Generic direct-acting antiviral agents: do they work well?

  8. Impact and management of patients with multiple hepatitis C virus genotypes

  9. Hepatitis C virus and injecting drug use: what are the challenges?

  10. Hepatitis B virus reactivation while on hepatitis C virus direct-acting antiviral therapy: is that a real concern and when is it a concern?

  11. Drug–drug interactions with direct-acting antivirals: when do we need to care?

Section 2: HBV, HDV, and HEV

  1. Management of acute hepatitis B infection: when should we offer antiviral therapy?

  2. Rethinking the inactive carrier state: management of patients with low-replicative HBeAg-negative chronic hepatitis B and normal liver enzymes

  3. Hepatitis B e antigen‐positive chronic hepatitis B infection with minimal changes on liver biopsy: what to do next?

  4. The management of hepatitis B virus in pregnancy

  5. Treatment of hepatitis B in children

  6. Hepatitis B vaccine failures: how do we handle them?

PART III: Clinical Set‐up and the Future

  1. Hepatitis C vaccines: how close are we to the promised land?

  2. Elimination of hepatitis C virus in high‐prevalence, low‐income countries: is it feasible?

  3. Hepatitis B virus diagnostics: anything new?

PART IV: Ongoing Controversies

  1. Is hepatocellular carcinoma risk impacted favorably or unfavorably by hepatitis C virus therapy with direct‐acting antivirals?

  2. Global elimination of hepatitis C virus by 2030: the optimistic view

  3. Global elimination of hepatitis C virus by 2030: the pessimistic view

People also search:

clinical dilemmas in viral liver disease
clinical liver disease board review questions
clinical liver diseases
liver disease 2022
b livers

Tags:

Graham Foster,Rajender Reddy,Clinical Dilemmas,Viral Liver Disease